3.8 Article

Pain relief by supraspinal gabapentin requires descending noradrenergic inhibitory controls

期刊

PAIN REPORTS
卷 3, 期 4, 页码 -

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PR9.0000000000000659

关键词

Gabapentin; Neuropathic pain; Noradrenergic; Conditioned place preference; Chemotherapy-induced neuropathic pain

资金

  1. NINDS NIH HHS [R35 NS097306, T32 NS105604] Funding Source: Medline

向作者/读者索取更多资源

Introduction: Gabapentin regulates pain processing by direct action on primary afferent nociceptors and dorsal horn nociresponsive neurons. Through an action at supraspinal levels, gabapentin also engages descending noradrenergic inhibitory controls that indirectly regulate spinal cord pain processing. Although direct injection of gabapentin into the anterior cingulate cortex provides pain relief independent of descending inhibitory controls, it remains unclear whether that effect is representative of what occurs when gabapentin interacts at multiple brain loci, eg, after intracerebroventricular (i.c.v.) injection. Methods: We administered gabapentin i.c.v. in a mouse model of chemotherapy (paclitaxel)-induced neuropathic pain. To distinguish spinal from supraspinally processed features of the pain experience, we examined mechanical hypersensitivity and assessed relief of pain aversiveness using an analgesia-induced conditioned place preference paradigm. Results: Paclitaxel-treated mice showed a preference for a 100-mu g i.c.v. gabapentin-paired chamber that was accompanied by reduced mechanical allodynia, indicative of concurrent engagement of descending controls. As expected, the same dose in uninjured mice did not induce place preference, demonstrating that gabapentin, unlike morphine, is not inherently rewarding. Furthermore, a lower dose of supraspinal gabapentin (30 mu g), which did not reverse mechanical allodynia, did not induce conditioned place preference. Finally, concurrent injections of i.c.v. gabapentin (100 mu g) and intrathecal yohimbine, an alpha 2-receptor antagonist, blocked preference for the gabapentin-paired chamber. Conclusion: We conclude that pain relief, namely a reduction of pain aversiveness, induced by supraspinal gabapentin administered by an i.c.v. route is secondary to its activation of descending noradrenergic inhibitory controls that block transmission of the pain message from the spinal cord to the brain.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据